Алексей Владимирович Потатурко

Алексей Владимирович Потатурко

Auto-generated profile, based on publicly available information

Алексей Владимирович Потатурко

Yekaterinburg Medical Research Center for Prevention and Health Protection of Workers at Industrial Enterprises

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2020 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
VSV. A. Shirokov
V. A. Shirokov
APA. V. Potaturko
A. V. Potaturko
NTN. L. Terekhov
N. L. Terekhov
Nonsteroidal anti-inflammatory drugs (NSAIDs) and muscle relaxants are used orally or intramuscularly (IM) to treat lumbar ischialgia caused by musculoskeletal disorders or radiculopathy. A comparative study has been conducted to investigate the efficacy and safety of the NSAID meloxicam (Amelotex®) injected intramuscularly and into the trigger points in combination with tolperisone and B-group vitamins for lumbar ischialgia. Patients and methods. The investigation enrolled 62 patients aged 30–60 years with lumbar ischialgia, who were randomized into three equal groups. Group 1 patients were injected with meloxicam 1.5 ml (15 mg of its active ingredient) into the trigger points daily for 3 days, followed by one 15-mg tablet daily for 14 days; Group 2 received IM meloxicam 15 mg daily for 3 days, followed by one 15-mg tablet daily for 14 days; Group 3 had IM meloxicam 15 mg daily for 3 days, followed by one 15-mg tablet daily for 14 days in combination with tolperisone (Calmirex®) as tablets: 150 mg (Day 1 of therapy), 300 mg (Day 2), and 450 mg daily (Day 3 until the end of therapy). All the patients received IM Vitamin B complex (Compligam B®) 2 ml for 5 days. The treatment efficiency was evaluated using the pain visual analogue scale (VAS), the Oswestry disability questionnaire, and the McGill pain questionnaire, the range of motion, and the severity of neurodystrophic syndrome. Results and discussion. All the patient groups showed a rapid and substantial pain reduction on the VAS and a functional activity improvement according to the Oswestry scale, which made it possible to complete the treatment within an average of 9.6 days. Groups 3 and 1 exhibited a faster improvement and, as a result, a shorter therapy duration on 8.6±1.2 and 9.2±0.9 days than did Group 2 (8.6±1.2 days). On day 2 of treatment, there was a more considerable pain reduction on the VAS in Group 1 that received meloxicam injections into the trigger zones. The administration of meloxicam intramuscularly and into the trigger zones in combination with tolperisone and vitamin B complex was noted to be safe and well tolerated. Conclusion. The injection of Amelotex into the trigger zones is highly effective and safe in treating lumbar ischialgia. An NSAID (meloxicam) in combination with a muscle relaxant (tolperisone) speeds up recovery and shortens the duration of NSAID intake.

23 April 2024 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
ESE.R. Shaikhlislamova
E.R. Shaikhlislamova
ASA.S. Shastin
A.S. Shastin
EVE.T. Valeeva
E.T. Valeeva
NTN.L. Terekhov
N.L. Terekhov
ADA.A. Distanova
A.A. Distanova
SGS.R. Guselnikov
S.R. Guselnikov
Musculoskeletal and connective tissue diseases (MSD) are highly prevalent in all public strata. Today, research on MSD prevalence among the working-age population is complicated by the lack of available information. Objective. To analyze the overall prevalence of MSD among the working-age population of the Volga Federal District (VFD) in 2020—2021 during the COVID-19 pandemic. Material and methods. The prevalence of MSD among the adult working-age population of VFD per 100.000 people was calculated in general and by certain nosologies. A nonparametric Wilcoxon test was used to assess the differences between all the studied indicators of the overall prevalence in 2020 and 2021. The critical level of significance for the absence of differences was 0.05. We used applied and descriptive statistics methods, Microsoft Excel program, and the Wolfram Research Mathematica v.11.3 system. Results. The study indicates a statistically significant decrease in the overall prevalence of MSD among the working-age population of most VFD entities in 2020—2021. We noted significant fluctuations in the overall prevalence rates in some regions by certain MSD nosologies, including statistically significant increases and statistically significant decreases. Thus, regarding the prevalence rates, the maximum overall prevalence of arthroses and arthropathies in 2020—2021 was registered in the Republic of Bashkortostan and was twice as high as the minimal rates registered in the Udmurt Republic and the Penza Region. Conclusion. We detected pronounced regional differences in the overall prevalence of MSD among the working-age population of VFD entities. The general trend was the increase in prevalence during the COVID-19 pandemic. Governing bodies of subjects in health protection and main freelance domain experts shall consider the features of disease prevalence among the working-age population when planning and implementing public health promotion programs.

28 March 2024 in Russian Journal of Pain
Verified
Journal Article
Closed access
VSV.A. Shirokov
V.A. Shirokov
KMK.S. Manko
K.S. Manko
NTN.L. Terekhov
N.L. Terekhov
APA.V. Potaturko
A.V. Potaturko
ANA.V. Novikova
A.V. Novikova
ISIgor Shohin
Igor Shohin
Objective. To evaluate the efficacy, safety, tolerability and pharmacokinetics of cyclobenzaprine in patients with abnormal muscle hypertonicity following nonspecific neck and lower back pain. Material and methods. A single-blind placebo-controlled multiple-center randomized study included 240 patients randomized into 2 groups by 120 people: the main group — cyclobenzaprine 10 mg 3 times a day for 14 days; the control group — placebo (1 tablet 3 times a day). Patients could take ibuprofen at a dose not exceeding 1200 mg daily as on-demand therapy. Steady-state cyclobenzaprine pharmacokinetics parameters were assessed in 18 patients of the main group. Results. Considering pain intensity, muscle spasm, soreness and ODI score, we can conclude higher efficiency of treatment in the main group compared to placebo. Cyclobenzaprine significantly reduces the need for additional intake of NSAIDs. Steady-state cyclobenzaprine Cmax,ss, Tmax,ss, AUC0-τ,ss were analyzed. There were mild-to-moderate adverse events in the main group with subsequent recovery in 72.50% of cases. There were no significant between-group differences in severity of adverse events. Conclusion. Cyclobenzaprine is effective and safe for nonspecific neck and lower back pain accompanied by muscle hypertonicity.

15 July 2024 in Sanitarnyj vrač (Sanitary Doctor)
Verified
Journal Article
Closed access
ESE. R. Shaikhlislamova
E. R. Shaikhlislamova
ABA. R. Basyrova
A. R. Basyrova
ASA. S. Shastin
A. S. Shastin
EVE. T. Valeeva
E. T. Valeeva
NTN. L. Terekhov
N. L. Terekhov
VGV. G. Gazimova
V. G. Gazimova
Diseases of the musculoskeletal system (MSMS) are highly common among the population, causing high rates of temporary and permanent disability in those affected. The problem is also determined by the wide age range of the sick — from young to elderly, which dictates the need to assess the prevalence and regional characteristics of musculoskeletal pathology among the population, including those of working age. The purpose of the study is to investigate the regional features of the primary incidence of the adult population of working age in the Volga Federal District (VFD) with diseases of class ICD-10 XIII (M00‑M99) «Diseases of the musculoskeletal system and connective tissue» during the COVID-19 pandemic in 2020–2021. Methods of descriptive and applied statistics were used in the research process. Statistical collections with information on the incidence of BCM in the adult population and the population over working age were studied. For a comparative assessment, we used the construction of a 95 % confidence interval for the average incidence value for the period 2012–2019. method of generating repeated samples (bootstrap). Growth rate ( %) of the incidence rate in 2020–2021. calculated to average values for 2012–2019. Using the non-parametric Wilcoxon test, the differences between the values of all studied indicators and primary incidence (PI) for 2020–2021 (p) were assessed. The variability of indicators was assessed using coefficients of variation (Cv). For statistical processing of the generated database, the Microsoft Excel program and the Wolfram Research Mathematica v.11.3 system were used. During the studied period, the adult population living in the Volga Federal District was characterized by a decrease in the incidence of diseases of the musculoskeletal system. Significant fluctuations in primary incidence were revealed. In 2020–2021 For most of the studied indicators, there was an increase in Cv of primary morbidity, differences in morbidity levels for individual nosological forms of diseases of the musculoskeletal system in the regions of the district. During the pandemic of the new coronavirus infection in the Volga Federal District, multidirectional changes in the levels of primary incidence of diseases of the musculoskeletal system were observed, which was most likely due to the limitation of the provision of specialized medical care in certain regions.

28 December 2023 in Hygiene and sanitation
Verified
Journal Article
Open access
PDF file
ВШВасилий Афонасьевич Широков
Василий Афонасьевич Широков
NTNikita L. Terekhov
Nikita L. Terekhov
АПАлексей Владимирович Потатурко
Алексей Владимирович Потатурко
Introduction. The pain in the lower back (BCC) has a wide distribution among the working people’s age and is a frequent cause of temporary disability. The identification of risk factors for the back pain is necessary to address expert issues and developing measures for prevention of incidence. Materials and methods. There were studied prevalence odds ratio (OR) for the development of the low back pain (LBP) in two thousand nine hundred fifteen working patients with different indicators of hardness of the labour process and levels of physical activity (PA). Results. According to the special assessment of the working conditions, the harmful (3rd) class of hardness of the labour process in comparison with the 1st and 2nd classes (optimal and permissible) increased the LBP prevalence from 31.6 to 37.1% with OR = 1.27 at 95% Ci (1.03–1.43), p <0.05. No reliable differences were obtained under comparing classes separately with the 1st class. According to the International questionnaire of physical activity, the LBP prevalence under an intensive PA is 29.3% with OR = 1.5 at 95% CI (1.6–2.11), at a low PA – 37.2% with OR = 2.15 at 95% Ci (1.07–4.3). The smallest LBP prevalence was revealed in a moderate PA mode throughout the day (21.6%). Limitations. The present study has a limitation associated with the inconsistency of cards for special assessment of working conditions and the International questionnaire cards. Conclusion. Data were obtained about the absence of reliable differences in the distribution and odds ratio for the development of LBP between workers by classes of hardness of the labour process. Workers with moderate and low PA have reliably low LBP prevalence.